Abstract |
After clinical diagnosis and microscopic confirmation, tinea cruris is best treated with a topical allylamine or an azole antifungal (strength of recommendation: A, based on multiple randomized controlled trials [RCTs]). Differences in current comparison data are insufficient to stratify the 2 groups of topical antifungals. Determining which group to use depends on patient compliance, medication accessibility, and cost. The fungicidal allylamines ( naftifine and terbinafine) and butenafine ( allylamine derivative) are a more costly group of topical tinea treatments, yet they are more convenient as they allow for a shorter duration of treatment compared with fungistatic azoles ( clotrimazole, econazole, ketoconazole, oxiconazole, miconazole, and sulconazole).
|
Authors | Dana Nadalo, Cathy Montoya, Dan Hunter-Smith |
Journal | The Journal of family practice
(J Fam Pract)
Vol. 55
Issue 3
Pg. 256-8
(Mar 2006)
ISSN: 0094-3509 [Print] United States |
PMID | 16510062
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Administration, Topical
- Antifungal Agents
(therapeutic use)
- Female
- Genital Diseases, Female
(drug therapy)
- Genital Diseases, Male
(drug therapy)
- Humans
- Male
- Tinea
(drug therapy)
|